Our Performance
Performance Highlights
As of December 2025
PERFORMANCE REPORTS
Read our annual performance reports to learn more about our development impact in Egypt and our efforts to promote a culture of impact-driven decision making.
i As of 12/31/2025 unless noted otherwise. EAEF monitors investments through regular data collection and targeted annual
surveys to better understand individual company and portfolio-level impact results.
ii IPOs include Contact Financial and Fawry, in which EAEF sold part of its stakes in each company in 2018 and 2019, respectively.
In 2022, EAEF sold its entire stake in Abu Auf to Agthia, a UAE investor. In 2025, EAEF sold its entire stake in Orchidia
Pharmaceutical to SPE Capital, a regional investment firm.
iii Includes any dividends, interest, and proceeds from exits, which are then reinvested by EAEF
iv FDI attracted to the EAEF portfolio reflects foreign equity capital invested in portfolio companies and managers at the time of, or following EAEF’s investment. Debt financing is excluded.
v EAEF uses the IFC Definition of MSMEs. Total Active Loans are attributable to EAEF direct investments in Fawry, Contact Financial and Tamweely
vi These results are attributed to EAEF’s direct investment in Nermien Ismail Schools
vii viii Results are attributable to EAEF direct investments in Dawi Clinics and Al-Tayseer Healthcare Group